Related Experiment Video
Updated: May 29, 2026

03:05
Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
[Prognostic factors for gastric cancer without lymph node involvement]
Oscar Tapia1, Miguel Villaseca, Enrique Bellolio
1Departamento de Anatomía Patológica, Facultad de Medicina, Universidad de La Frontera, Temuco, Chile. otescalona@gmail.com
Summary
Gastric cancer patients with no lymph node involvement (N0) have better survival, but some still face poor prognosis. Tumor size, infiltration depth, and differentiation are key independent prognostic factors for N0 gastric tumors.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Context:
- Gastric cancer prognosis is heavily influenced by lymph node status.
- While node-negative (N0) gastric cancer generally indicates a better outlook, a subset of these patients experiences unfavorable outcomes.
- Identifying specific prognostic indicators within the N0 subgroup is crucial for accurate risk stratification.
Purpose:
- To investigate demographic and morphological variables predicting prognosis in N0 gastric carcinoma.
- To identify independent prognostic factors in surgically treated N0 gastric cancer patients.
Summary:
- A review of 459 gastrectomies for gastric cancer revealed 32% were N0, with a 71% five-year survival rate.
- Bivariate analysis identified age, tumor size, wall infiltration, pathological type, lymphovascular invasion, lymph node yield, and TNM stage as prognostic indicators.
- Multivariate analysis confirmed gastric wall infiltration, poor differentiation, lymphovascular invasion, lymph node yield, and tumor size as independent prognostic factors.
Impact:
- Establishes key independent prognostic factors for N0 gastric cancer, including tumor size, infiltration, differentiation, and lymphovascular invasion.
- Provides valuable information for refining risk assessment and treatment strategies for node-negative gastric cancer patients.
- Contributes to a better understanding of tumor biology and patient outcomes in a significant subset of gastric cancer cases.
